Results 51 to 60 of about 3,238 (182)

Validation of the 9th Edition of the Tumor‐Node‐Metastasis Staging System for Non‐Metastatic Nasopharyngeal Carcinoma: A Multicenter Retrospective Analysis From High‐Incidence Regions

Cancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Objective To evaluate and compare the prognostic value of the 8th and 9th editions of the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system in patients with non‐metastatic nasopharyngeal carcinoma (NPC).
Yongquan Wei, Danxue Qin, Baoqing Yang, Bin Deng, Qianxian Luo, Lihong Huang, Jiazhang Wei, Shaojie Zhang, Weiming Deng, Guiping Lan, Min Li, Shenhong Qu, Jingjin Weng   +12 more
wiley   +1 more source

Clinical outcomes of percutaneous microwave ablation for pulmonary oligometastases from hepatocellular carcinoma: a retrospective, multicenter study

Cancer Imaging
Background Pulmonary oligometastases are common in hepatocellular carcinoma (HCC), however, the existing therapeutic options have several limitations. This study aimed to assess the safety and efficacy of microwave ablation (MWA) in the treatment of HCC ...
Gang Wang, Zhigang Wei, Feihang Wang, Xiaoying Han, Haipeng Jia, Danyang Zhao, Chunhai Li, Lingxiao Liu, Xia Yang, Xin Ye   +9 more
doaj   +1 more source

Abscopal Effect in Radiation Therapy: The Immune Mechanisms and Clinical Advances

MedComm, Volume 7, Issue 9, September 2026.
The schematic outlines the key events of the abscopal effect. (Ignition) Local radiotherapy (RT) induces the release of immunogenic signals from the tumor, leading to dendritic cell (DC) activation. (Orchestration) In the tumor‐draining lymph node (TDLN), DCs prime naive T cells into cytotoxic T lymphocytes (CTLs), a process modulated by regulatory T ...
Yihong Dong, Moran Chen, Xupeng Hou, Xiaoya Tang, Xiaoli Yu, Jing Liu   +5 more
wiley   +1 more source

Simultaneous integrated boost with intensity modulated radiation therapy in brain oligometastases: A feasible technique for developing countries

South Asian Journal of Cancer, 2015
Introduction: To analyze the pattern of brain metastasis (BM), and to use intensity modulated radiation therapy (IMRT) for target dose escalation in cases with ≤3 metastatic lesions (oligometastases).
Vivek Tiwari, Subodh C Pande, Kamal Verma, Sandeep Goel   +3 more
doaj   +1 more source

Local Control Following Stereotactic Body Radiation Therapy for Liver Oligometastases: Lessons from a Quarter Century

Current Oncology, 2023
The utilization of stereotactic body radiation therapy for the treatment of liver metastasis has been widely studied and has demonstrated favorable local control outcomes.
Sara Mheid, Stefan Allen, Sylvia S. W. Ng, William A. Hall, Nina N. Sanford, Todd A. Aguilera, Ahmed M. Elamir, Rana Bahij, Martijn P. W. Intven, Ganesh Radhakrishna, Issa Mohamad, Jeremy De Leon, Hendrick Tan, Shirley Lewis, Cihan Gani, Teo Stanecu, Veronica Dell’Acqua, Ali Hosni   +17 more
doaj   +1 more source

Stereotactic radiotherapy for oligometastases in the lymph nodes

Reports of Practical Oncology and Radiotherapy, 2022
Even though systemic therapy is standard treatment for lymph node metastases, metastasis-directed stereotactic radiotherapy (SRT ) seems to be a valid option in oligometastatic patients with a low disease burden. Positron emission tomography-computed tomography (PET-CT ) is the gold standard for assessing metastases to the lymph nodes; co-registration ...
Pasqualetti F., Trippa F., Aristei C., Borghesi S., Colosimo C., Cantarella M., Mazzola R., Ingrosso G.   +7 more
openaire   +3 more sources

Real‐world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO study

International Journal of Cancer, Volume 159, Issue 3, Page 683-698, 1 August 2026.
What's New? Although patients with melanoma brain metastases (MBM) may benefit from treatment with immune checkpoint inhibitors (ICIs), which are known to improve survival in advanced melanoma, MBM patients have often been excluded from trials evaluating ICIs.
Ralf Gutzmer, Michael Weichenthal, Thomas Eigentler, Peter Mohr, Thomas Sickmann, Pia Dücker, Christoffer Gebhardt, Sebastian Haferkamp, Katharina C. Kähler, Friedegund Meier, Claudia Pföhler, Anca Sindrilaru, Patrick Terheyden, Imke von Wasielewski, Selma Ugurel, Jens Ulrich, Jochen Utikal, Carsten Weishaupt, Dirk Schadendorf   +18 more
wiley   +1 more source

Recurrent Extradural Myxopapillary Ependymoma With Oligometastatic Spread

Frontiers in Oncology, 2019
Myxopapillary ependymomas are a slow-growing, grade I type glial tumor in the lumbosacral region. More rarely, they can present as extradural, subcutaneous sacrococcygeal, or perisacral masses, and it is under these circumstances that they are more ...
Kristen A. Batich, Kristen A. Batich, Kristen A. Batich, Richard F. Riedel, Richard F. Riedel, John P. Kirkpatrick, John P. Kirkpatrick, John P. Kirkpatrick, John P. Kirkpatrick, Betty C. Tong, Betty C. Tong, William C. Eward, William C. Eward, Char Loo Tan, Char Loo Tan, Patricia D. Pittman, Roger E. McLendon, Roger E. McLendon, Roger E. McLendon, Katherine B. Peters, Katherine B. Peters, Katherine B. Peters   +21 more
doaj   +1 more source

Stereotactic Radiation for Oligometastatic and Oligoprogressive Stage IV Breast Cancer: A Case-Based Review

Current Oncology, 2023
For decades, the distant progression of breast cancer has been the purview of systemic therapy alone or with low to moderate-dose radiation therapy intended for the palliation of symptomatic metastases.
Gary M. Freedman, Joshua A. Jones, Neil K. Taunk   +2 more
doaj   +1 more source

Oligometastases/Oligo-Recurrence of Lung Cancer [PDF]

Pulmonary Medicine, 2013
Metastasis or recurrence of cancer has been considered as representing a near terminal life stage. As a result, for a long time, cancer patients with metastasis or recurrence have been classified as one group and treated using only systemic therapy. However, recent advances in cancer therapy have dramatically improved both local and systemic therapies.
Yuzuru Niibe, Joe Y. Chang, Hiroshi Onishi, Joseph Salama, Takao Hiraki, Hideomi Yamashita   +5 more
openaire   +3 more sources